Escobar MM, GV Carbonell GV, Beriam LOS, Siqueira WJ, Yano T

Language: English
References: 17
Page: 165-170
PDF size: 188.60 Kb.

ABSTRACT

In this work, culture filtrates of entomopathogenic and phytopathogenic Serratia marcescens strains induced cytotoxic effects on CHO, Vero and HEp-2 cell lines. Morphological changes on sensitive cells were characterized by cell rounding and detachment as soon as 30 min of incubation, culminating in cell death after 24 h. The cytotoxic effect was completely neutralized by specific antiserum indicating that occur antigenic similarity among cytotoxins produced by these strains. The toxicity assays on plants showed that the culture supernatants did not provoke any visible morphological change and did not affect their growth. By contrast, the plants treated with bacterial suspension showed disease symptom, such as shriveling and decay of stores bulbus in onion and lettuce plantlets. In conclusion, this study show that phytopathogenic and entomopathogenic S. marcescens may produce a cytototoxin similar to that produced by clinical isolates and it is toxic to different mammalian cell lines. These results are especially important for studies involving this bacterium as biological control agent.

REFERENCES

1. Beriam, L.O.S., Siigaglia, C., and Rodrigues Neto, J. 1990. Serratia marcescens associada a podridão de cebola armazenada. Fitopatol. Bras. 18:296.

2. Campbell, J.R., Diacovo, T., and Baker, C.J. 1992. Serratia marcescens meningitis in neonates. Ped. Infect. Dis. J. 11:881-886.

3. Carbonell, G.V., Alfieri,. A.F., Alfieri, A.A., Vidotto, M.C., Levy, C.E., Darini, A.L.C., and Yanaguita, R.M. 1997. Detection of cytotoxic activity on Vero cells in clinical isolates of Serratia marcescens. Braz. J. Med. Biol. Res. 30:1291-1298.

4. Carbonell, G.V., Della Colleta, H.H.M., Yano, T., Darini, A.L.C., Levy, C.E., and Fonseca, B.A.L. 2000. Clinical relevance and virulence factors of pigmented S. marcescens. FEMS Immun. Med. Microbiol. 28:143-149.

5. Carbonell, G.V., Fonseca, B.A.L., Figueiredo, L.T.M., Darini, A.L.C., and Yanaguita, R.M. 1996. Culture conditions affect cytotoxin production by Serratia marcescens. FEMS Immun. Med. Microbiol. 16:299-307.

6. Finlay, B.B., and Falkow, S. 1989. Common themes in microbial pathogenicity. Microbiol. Rev. 53:210-230.

7. Grimont, P.A.D., Grimont, F., and Lysenko, O. 1979. Species and biotype identification of Serratia strains associated with insects. Curr. Microbiol. 2:139-142.

8. Ito, M.F., Paradela Filho, O., Rodrigues Neto, J., Beriam, L.O.S., Longo, R.S., and Santos, J.M. 1996. Ocorrência de Serratia marcescens Bizio sobre lagartas de Heliothis virescens (Fabr.). Bragantia, 55(2):289-292.

9. Kaška, M., Lysenko, O., and Chaloupka, J. 1976. Exocellular proteases of Serratia marcescens and their toxicity to larvae of Galleria mellonella. Folia Microbiol, 21:465-473.

10. Lysenko, O. 1976. Chitinase of Serratia marcescens and its toxicity to insects. J. Invertebr. Pathol. 27:385-386.

11. Meltz, D.J., and Grieco, M.H. 1973. Characteristics of Serratia marcescens pneumonia. Arch. Int. Med. 132:359-364.

12. Murashige, T. and Skoog, F. 1962. A revised medium for rapid growth and bioassays with tobacco tissue culture. Physiol. Plant. 5:473-497.

13. Nakashima, A.K., McCarthy, M.A., Martone, W.J., and Anderson, R.L. 1987. Epidemic arthritis caused by Serratia marcescens and associated with a benzalkonium chloride antiseptic. J. Clin. Microbiol. 25:1014.

14. Okuda, T., Endo, N., and Osada, Y. 1981. Outbreak of nosocomial urinary tract infections caused by Serratia marcescens. J. Clin. Microbiol. 20:691-695.

15. Parreira, V.R., and Yano, T. 1998. Cytotoxin produced by Escherichia coli isolated from chickens with swollen head syndrome (SHS). Vet. Microbiol. 62:111-119.

16. Thelestam, M., and Florin, I. 1994. Assay of cytopathogenic toxins in cultured cells. Methods Enzymol 235:679-690.

17. Volkow-Fernández, P., Léon-Rosales, S.P., Sifuentes-Osornio, J., Calva-Mercado, J.J., Ruiz-Palacios, G.M., and Ma. Cérbon. 1993. Epidemia de bacteremias primarias por una cepa endémica de Serratia marcescens en una unidad de terapia intensiva. Salud Pública de México 35:440-7.